Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial
Journal of Clinical Oncology · 17.11.2026
DOI: 10.1200/jco-26-00969 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, online erschienen am 17.11.2026. Verfasst von Bruno Meduri und 39 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Purpose
The aim of this study was to investigate whether external-beam accelerated partial-breast irradiation (APBI) provides noninferior local control compared with whole-breast irradiation (WBI). Patients and Methods We conducted this randomized phase III trial (ClinicalTrials.gov identifier: NCT01803958 ) in 35 centers. Patients age ≥49 years with invasive breast cancer, resection margins ≥2 mm, tumor diameter ≤3 cm, and pN0-1 were randomly assigned 1:1 to WBI or APBI (38.5 Gy in 10 fractions twice daily). Neither patients nor investigators were masked to treatment allocation. The primary end point was ipsilateral breast tumor recurrence (IBTR), analyzed according to the modified intention-to-treat analysis. We assumed a 5-year IBTR rate of 4% in the WBI group to exclude a 2% increase in the APBI group (90% power; noninferiority margin hazard ratio [HR], 1.5).
Results
Between 2007 and 2019, 3,309 patients were randomly assigned (1,652 to APBI, 1,657 to WBI); 84 were excluded from the analysis. The median follow-up was 97.5 months. The 5-year cumulative IBTR incidence was 1.0% (95% CI, 0.6 to 1.6) for APBI and 0.8% (95% CI, 0.5 to 1.4) for WBI. The HR for APBI versus WBI was 1.18 (90% CI, 0.63 to 2.20) with the upper confidence limit crossing the prespecified noninferiority margin.
Conclusion
At 5 years, the cumulative incidence of IBTR is exceptionally low (≤1%) in both arms. Although formal statistical noninferiority was not demonstrated because the upper confidence limit crossed the margin, the absolute difference was
Zitieren
APA
Meduri, B., Baldissera, A., Iotti, C., Scheijmans, L. J., Stam, M. R., Parisi, S., Boersma, L. J., Ammendolia, I., Koiter, E., Canino, P., Busz, D. M., Kroese, M. S., Giacobazzi, P., Ruggieri, M. P., Engelen, A., Munafò, T., Verhoeven, K., Valli, M., Vicini, R., …, & Scandolaro, L. (2026). Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00969
Vancouver
Meduri B, Baldissera A, Iotti C, Scheijmans LJ, Stam MR, Parisi S, et al. Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial. Journal of Clinical Oncology. 2026. doi:10.1200/jco-26-00969
BibTeX
@article{Meduri2026,
author = {Meduri, Bruno and Baldissera, Antonella and Iotti, Cinzia and Scheijmans, Luc J.E.E. and Stam, Marcel R. and Parisi, Salvatore and Boersma, Liesbeth J. and Ammendolia, Ilario and Koiter, Eveline and Canino, Paola and Busz, Dianne M. and Kroese, Marika Stenfert and Giacobazzi, Patrizia and Ruggieri, Maria P. and Engelen, Antoine and Munafò, Tindara and Verhoeven, Karolien and Valli, Mariacarla and Vicini, Roberto and Costantini, Riccardo Cuoghi and D'Angelo, Elisa and Lohr, Frank and D'Amico, Roberto and Frezza, Giovanni and Poortmans, Philip and Ciabatti, Selena and Bertoni, Filippo and Zanella, Elena and Guidi, Gabriele and Scicolone, Stefano and Kaleci, Shaniko and Tazzioli, Giovanni and Cossa, Sabrina and Iannelli, Alessandra and Corsa, Pietro and Troiano, Michele and Khali, El Jaouni Mohammad and Tolento, Giorgio and Morganti, Alessio G. and Scandolaro, Luciano},
title = {Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial},
journal = {Journal of Clinical Oncology},
year = {2026},
doi = {10.1200/jco-26-00969}
}
EUVIMED